Close Menu


Ambry will offer services for sequence enrichment and resequencing validation using RainDance Technologies' RDT 1000 system.

Ambry said the chip offers a "higher-resolution approach" to standard karyotyping for stem cells, as well as increased coverage in known stem cell- and cancer-associated genes compared to Agilent's standard 44K CGH array.

Ambry Genetics and ImaGenes are partnering with SoftGenetics and CLC Bio, respectively, to provide more in-depth bioinformatics services for their customers.

The strategic alliance gives Ambry's sequencing customers use of the NextGENe analysis software.

Athena alleges that Ambry's sale of tests for certain types of diabetes infringes on patents that Athena licensed from its development partner Correlagen.

Ambry was certified to use the SureSelect target enrichment technology for next-gen sequencing services.

New Product Watch


Genedata, Ambry Genetics, Arrayit, NanoInk

The company passed certification for using Agilent's arrays for genomics researchers.


The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.